<DOC>
	<DOC>NCT02386839</DOC>
	<brief_summary>This observational study will compare safety and efficacy treatment outcomes in infants that received study drug treatment with infants that received standard neonatal care in Study ROPP-2008-01 (NCT01096784).</brief_summary>
	<brief_title>Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROP-2008-01 for the Prevention of ROP</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Retinopathy of Prematurity</mesh_term>
	<criteria>1. Subject was randomized in Study ROPP200801, Section D 2. Subject's parent or legally authorized representative(s) must provide written informed consent prior to performing any studyrelated activities. Studyrelated activities are any procedures that would not have been performed during normal management of the subject. 1. Any other condition or therapy that, in the Investigator's opinion, may pose a risk to the subject or interfere with the subject's ability to be compliant with this protocol or interfere with the interpretation of results 2. The subject or subject's parent or legally authorized representative(s) is unable to comply with the protocol as determined by the Investigator</criteria>
	<gender>All</gender>
	<minimum_age>40 Weeks</minimum_age>
	<maximum_age>52 Weeks</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>